These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 31583970

  • 1. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for Bulkholderia cepacia reacutization.
    Saffioti C, Barco S, Cangemi G, Mesini A, Casciaro R, Cresta F, Castellani C, Bandettini R, Morelli P, Castagnola E.
    J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970
    [No Abstract] [Full Text] [Related]

  • 2. Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.
    Spoletini G, Etherington C, Shaw N, Clifton IJ, Denton M, Whitaker P, Peckham DG.
    J Antimicrob Chemother; 2019 May 01; 74(5):1425-1429. PubMed ID: 30649419
    [Abstract] [Full Text] [Related]

  • 3. Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis.
    Daccò V, Claut L, Piconi S, Castellazzi L, Garbarino F, Teri A, Colombo C.
    Transpl Infect Dis; 2019 Jun 01; 21(3):e13082. PubMed ID: 30892778
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam.
    Van Dalem A, Herpol M, Echahidi F, Peeters C, Wybo I, De Wachter E, Vandamme P, Piérard D.
    Antimicrob Agents Chemother; 2018 Sep 01; 62(9):. PubMed ID: 29914964
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections.
    El-Halfawy OM, Naguib MM, Valvano MA.
    Antimicrob Resist Infect Control; 2017 Sep 01; 6():120. PubMed ID: 29204272
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of resistant Burkholderia multivorans infection in a patient with cystic fibrosis using ceftazidime/avibactam plus aztreonam.
    Barlow G, Morice A.
    J Antimicrob Chemother; 2018 Aug 01; 73(8):2270-2271. PubMed ID: 29912407
    [No Abstract] [Full Text] [Related]

  • 12. Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.
    Tamma PD, Fan Y, Bergman Y, Sick-Samuels AC, Hsu AJ, Timp W, Simner PJ, Prokesch BC, Greenberg DE.
    Antimicrob Agents Chemother; 2018 Apr 01; 62(4):. PubMed ID: 29588357
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of Burkholderia cepacia Complex to Ceftazidime/Avibactam and Standard Drugs of Treatment for Cystic Fibrosis Patients.
    Schaumburg F, Idelevich EA, Mellmann A, Kahl BC.
    Microb Drug Resist; 2022 May 01; 28(5):545-550. PubMed ID: 35512733
    [Abstract] [Full Text] [Related]

  • 14. Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child.
    Magalhães M, de Britto MC, Vandamme P.
    J Cyst Fibros; 2002 Dec 01; 1(4):292-4. PubMed ID: 15463830
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J, Chen Y, Tabibi S, Alba L, Garber E, Saiman L.
    Antimicrob Agents Chemother; 2007 Mar 01; 51(3):1085-8. PubMed ID: 17158942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
    Ball R, Brownlee KG, Duff AJ, Denton M, Conway SP, Lee TW.
    J Cyst Fibros; 2010 Jan 01; 9(1):73-4. PubMed ID: 19932062
    [No Abstract] [Full Text] [Related]

  • 19. In Vitro Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli.
    Mazer DM, Young C, Kalikin LM, Spilker T, LiPuma JJ.
    Antimicrob Agents Chemother; 2017 Sep 01; 61(9):. PubMed ID: 28674053
    [Abstract] [Full Text] [Related]

  • 20. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
    Etherington C, Peckham DG, Conway SP, Denton M.
    J Cyst Fibros; 2003 Dec 01; 2(4):220-1. PubMed ID: 15463878
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.